Erratum to “A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery disease” [Atherosclerosis 2004;174(2):349–356]

Fig. 3. Detection of apoproteins in complexes by Western blotting. (a) Apoprotein staining of the VLDL (lane 1) of coronary atherosclerosis patients with low levels of SAA/LDL, and the SAA-unbound VLDL (lane 2) and SAA/VLDL (lane 3) of coronary atherosclerosis patients. (b) Apoprotein staining of the LDL (lane 1) of coronary atherosclerosis patients with low levels of SAA/LDL, and the SAA-unbound LDL (lane 2) and SAA/LDL (lane 3) of coronary atherosclerosis patients.